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GERALD D. ABRAMS, MD, M. ANTHONY SCHORK, PhD, and 
BENEDICT R. LUCCHESI, PhD, MD 
Normal, marginal, and central ischemic regional 
myocardial function were evaluated in a canine 
model of myocardial infarction during 90 minute left 
circumflex coronary artery occlusion in 25 anes- 
thetized dogs randomly assigned to intravenous 
ibuprofen infusion (n = 13,5.36 mg/kg/h beginning 
1 hour before occlusion) or vehicle solution as 
control (n = 12) and in 15 conscious, unsedated 
dogs 48 and 72 hours after 90 minute circumflex 
artery occlusion followed by reperfusion (ibuprofen, 
5.36 mg/kg/h by intravenous infusion over 7 hours 
beginning 1 hour before occlusion, n = 7; or vehicle 
solution infusion as control, n = 8). 
Miniature subendocardial sonomicrometer crystal 
pairs were used to calculate left ventricular regional 
end-diastolic segment length, end-systolic segment 
length, and regional percent systolic shortening. 
Infarct size was estimated in 72 hour animals by a 
postmortem dual perfusion technique using tri- 
phenyltetrazolium histochemical dye and Evan’s 
blue dye for determination of infarct area, risk area, 
and area not at risk. Ibuprofen treatment significantly 
reduced infarct size expressed as percent of risk 
area (mean f standard deviation of 44.6 f 18 
versus 64.4 f 16% for control dogs, p <0.05) but it 
did not improve normal, marginal, or ischemic region 
end-diastolic length, end-systolic length or percent 
systolic shortening during coronary occlusion in 
anesthetized dogs or after reperfusion in conscious 
animals at 48 and 72 hours, and it did not enhance 
inotropic reserve at 72 hours in conscious animals. 
During 90 minute circumflex occlusion in anesthe- 
tized dogs, ibuprofen was associated with increases 
in systemic arterial pressure and worsened ischemic 
regional percent systolic shortening. 
Thus, ibuprofen does not improve normal, mar- 
ginal, or ischemic zone regional myocardial function 
during acute ischemia or 48 or 72 hours after myo- 
cardial reperfusion despite a significant reduction 
of infarct size. 
Reducing the extent of ischemic injury has been pro- 
posed as a rational goal in the management of acute 
myocardial infarction.’ Initial attempts to achieve this 
goal centered primarily on hemodynamic interventions 
which lessened myocardial oxygen consumption or 
improved blood flow or oxygen delivery to ischemic 
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myocardium; more recent investigations have evaluated 
a variety of agents whose primary effect is not hemo- 
functional integrity of the salvaged mvocardium or the 
dynamic but rather anti-inflammatory. The hypothesis 
supporting the use of these agents is that a significant 
determinant of ultimate ischemic injury is the inflam- 
matory process itself. Among the many agents currently 
under evaluation is ibuprofen, a nonsteroidal antiin- 
flammatory agent clinically employed for rheumatic 
disease.* Experimental studies have demonstrated a 
myocardial protective effect of ibuprofen in a variety 
of animal models,3-7 presumably attributable to its 
antiinflammatorv actions which affect arachidonic acid 
metabolism and-consequent physiologic events.8 
However, few studies on myocardial infarct size re- 
duction involving either hemodynamic or antiinflam- 
matory interventions have addressed the issue of the 
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effect of these agents on the function of myocardium 
removed from the area of ischemic injury. In order to 
assess the myocardial protective effect of ibuprofen on 
regional myocardial function, the following investiga- 
tion was undertaken using implantable subendocardial 
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sonomicrometer crystals to measure segment length 
changes in normal, marginal and ischemic regions9 in 
a canine model of left circumflex coronary artery oc- 
clusion and reperfusion. In this study, regional myo- 
cardial function was evaluated in open-chest, anesthe- 
tized dogs during coronary artery occlusion and in 
conscious, unsedated dogs 48 and 72 hours after cir- 
cumflex occlusion and subsequent myocardial reper- 
fusion. 
Methods 
Regional Myocardial Function During Coronary 
Artery Occlusion 
Coronary occlusion: In order to assess the acute effects 
of ibupiofen on regional function during evolving myocardial 
injuiry due to coronary artery occlusion, 25 dogs were studied 
in the open-chest anesthetized state. Healthy male mongrel 
dogs weighing 10.2 to 18.9 kg (mean f standard deviation 13.9 
f 1.9) were anesthetized with 30 mg/kg intravenous sodium 
pentobarbital and mechanically ventilated on room air by a 
Harvard animal respirator (Harvard Apparatus, Millis, 
Massachusetts) using an endotracheal tube. A left 5th inter- 
costal space thorocotomy was performed and the pericardium 
incised and sutured to form a pericardial cradle. The left cir- 
cumflex coronary artery was isolated distal to the left atria1 
appendage proximal to major branches. A zone of cyanosis was 
determined to be at least 9 cm2 during transient (10 to 15 
second) coronary occlusion. Three pairs of commercially 
manufactured miniature (3 mm) piezoelectric crystals (800 
kHz frequency in radial mode with a resolution capability of 
0.1 to 0.5 mm) connected to an oscilloscope sonomicrometer 
(Norland Instruments sonomicrometer crystals and NI-202 
sonomicrometer) were implanted 1 to 2 cm apart in the left 
ventricular subendocardium (Fig. 1). One crystal pair (central 
ischemic zone) was implanted in the posterolateral left ven- 
tricular surface in the center of the cyanotic zone as deter- 
mined by the transient circumflex occlusion, and a 2nd pair 
(marginal area) was implanted in the anterolateral left ven- 
FIGURE 1. Diagram of subendocardial sonomicrometer crystal 
placement in normal, marginal, and central ischemic left ventricular 
regions. LCX = left circumflex coronary artery. See text for discus- 
sion. 
tricular wall to straddle the border between cyanotic and 
noncyanotic zones. The marginal area was defined in the 
present study as a region of intermediate function between 
normal and ischemic zones.9 Normal zone sonomicrometer 
crystals were implanted on the anterior left ventricular wall 
in the region supplied by the left anterior descending coronary 
artery well removed from the ischemic area as determined by 
the zone of cyanosis. The crystals were implanted in a plane 
perpendicular to the base-apex cardiac axis and secured by 
an epicardial suture around the connecting wires as they 
emerged from the myocardium. Repeated calibrations at 1 ~LS 
intervals were obtained to eliminate variation due to signal 
drift. 
In addition, a small left neck incision was made for insertion 
of a polyethylene carotid artery catheter for blood pressure 
measurement and an external jugular catheter for infusion of 
ibuprofen or control solution. The carotid artery catheter was 
connected to a Statham P23DC pressure transducer. Mean 
arterial pressure was calculated as diastolic pressure plus one 
third of the pulse pressure. 
Ibuprofen infusion: Crystalline ibuprofen (sodium salt) 
was dissolved in 0.2 M sodium carbonate and adjusted to a pH 
of 8 by 1.0 N HCl. Solutions were mixed fresh before each 
experiment and diluted to 50 ml in physiologic saline solution. 
The ibuprofen dose employed was 5.36 mg/kg/h (7.14 ml/h of 
ibuprofen solution) by continuous intravenous infusion be- 
ginning 1 hour before occlusion and continuing throughout 
occlusion (90 minutes). This dose is similar to that used in a 
previous investigation6 with the exception of initiation of the 
infusion before occlusion in the present study. Vehicle solution 
prepared in an identical manner without ibuprofen served as 
a control. A Harvard infusion pump was used to provide a 
constant infusion rate. Animals were randomly assigned to 
their treatment groups (13 ibuprofen, 12 control). A lead II 
electrocardiogram was monitored throughout the experi- 
ment. 
After instrumentation, visible epicardial arterial anasto- 
moses between the left anterior descending and circumflex 
coronary arteries were ligated to eliminate potentially large 
collateral routes of blood flow.‘O A subtotal left circumflex 
coronary artery stenosis was produced just distal to the left 
atria1 appendage by tying 1-O silk suture around both the ar- 
tery and an 18 gauge needle followed by immediate needle 
removal; subsequent total circumflex artery occlusion was 
performed after 10 minutes with a total duration of occlusion 
of 90 minutes. Three mg/kg of intravenous lidocaine and 3 
mg/kg of intramuscular lidocaine were administered at the 
time of coronary artery occlusion as antiarrhythmic therapy.” 
Approximately one fourth of the animals developed ventric- 
ular fibrillation during coronary occlusion, which was readily 
converted to sinus rhythm within 30 to 60 seconds by low 
energy (10 to 20 J) direct. current cardioversion using epicar- 
dial paddles. No myocardial dysfunction has been reported 
at these energy levels.12 
Regional myocardial segment length: Measurement of 
regional myocardial segment length was obtained by con- 
verting sonomicrometer crystal transit time in microseconds 
to distance in millimeters using a known value for the velocity 
of ultrasound in myocardium at the frequency employed: 
Distance (mm) = transit time (I.CS) X ultrasound velocity in 
myocardium (1.58 mm/ps).l3 Before occlusion, end-diastolic 
length was defined in each segment as the maximal crystal 
separation in millimeters before the onset of the carotid artery 
systolic pressure rise, and end-systolic length was defined as 
the minimal crystal separation in millimeters before the di- 
erotic notch of the carotid artery pressure tracing. Nonsim- 
ultaneous end-diastolic or end-systolic timing in marginal or 
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ischemic segments in relation to normal segments was noted 
before occlusion and used as a reference to determine end- 
diastole and end-systole in the presence of dyskinesia during 
coronary artery occlusion. Measurement of absolute end- 
diastolic and end-systolic length in millimeters were obtained 
and regional percent systolic shortening defined as end-dia- 
stolic minus end-systolic length divided by end-diastolic 
length X100%. Subendocardial crystal placement was con- 
firmed by postmortem examination. 
A Grass model 7 polygraph was used to record measure- 
ments at a paper speed of 100 mm/s. Determination of carotid 
artery pressure, heart rate, and regional segment lengths and 
percent systolic shortening were obtained before and at the 
end of 90 minutes of coronary occlusion. All measurements 
were obtained at end-expiration and when the animal was free 
of arrhythmias. 
Regional Myocardial Function 48 and 72 Hours After 
Coronary Artery Occlusion-Reperfusion 
The effect of ibuprofen on regional myocardial function and 
infarct size was evaluated in conscious, unsedated dogs after 
left circumflex coronary artery occlusion with subsequent 
myocardial reperfusion in the anesthetized state. Fifteen 
healthy male mongrel dogs weighing 13.6 + 1.5 kg (range 10.2 
to 15.8) were used. Instrumentation, baseline regional function 
measurements, and 90 minute circumflex occlusion followed 
by reperfusion were performed using aseptic technique in 
pentobarbital anesthetized, open-chest dogs as in the acute 
occlusion study. Animals were randomly assigned to either 
ibuprofen (n = 7) or vehicle as control (n = 8). Solutions were 
prepared as before and administered intravenously by Har- 
vard infusion pump over 7 hours beginning 1 hour before oc- 
clusion with an ibuprofen dose of 5.36 mg/kg/h (7.14 ml/h of 
ibuprofen solution) or with an identical volume of vehicle as 
a control. Ischemic zone sonomicrometer crystals were asso- 
ciated with greater postoperative mortality in preliminary 
studies and therefore implanted in only 4 animals in each 
group. As in the acute occlusion study, a critical circumflex 
stenosis was placed 10 minutes before total occlusion using 
an 18 gauge needle and 1-O silk suture. A Carolina Medical 
Electronics electromagnetic flow probe was placed around the 
circumflex artery proximal to the subtotal occlusion to doc- 
ument a critical stenosis (defined as a stenosis causing at least 
a 50% reduction in peak reactive hyperemic flow after 10 
seconds of coronary occlusion without altering basal flow or 
sonomicrometer crystal segment length). This subtotal critical 
stenosis was left in place throughout the remainder of the 
experiment (until the animals were killed at 72‘hours). 
Coronary occlusion and reperf!sion: Total left cir- 
cumflex occlusion was performed using soft plastic tape for 
90 minutes and the occlusion was slowly released over 5 to 10 
minutes. Intravenous lidocaine, 3 mg/kg, was administered 
on reperfusion. Reperfusion occurred in all animals as docu- 
mented by 3 or more of the following criteria: (1) the onset of 
ventricular arrhythmias within 15 to 30 minutes of occlusion 
release; (2) a decrease in marginal and ischemic region end- 
diastolic and end-systolic segment length on release of the 
occlusion; (3) at least 5 ml/min of circumflex artery flow on 
occlusion release documented by electromagnetic flow probe; 
and (4) the absence of visible coronary artery thrombosis at 
72 hours when the animal was killed. 
After reperfusion, the chest was closed and the animals 
were allowed to recouer. Intramuscular ampicillin, 6 mg/kg, 
was administered twice on the day of surgery and daily 
thereafter. No recordings were obtained until 48 hours after 
surgery because of frequent ventricular arrhythmias. At 48 
and 72 hours, recordings of sonomicrometer crystal segment 
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lengths were obtained in the conscious, unsedated state with 
the animal standing upright in a nylon sling. In order to assess 
residual ventricular contractile function, inotropic reserve was 
also tested at 72 hours after coronary occlusion-reperfusion, 
5 minutes after administration of the beta-adrenergic stim- 
ulant prenalterol(30 pg/kg intravenous bolus).‘* 
Determination of infarct size and risk area: Animals 
were then reanesthetized with sodium pentobarbital, the chest 
was reopened, and the hearts were electrically fibrillated and 
rapidly excised for immediate postmortem in vitro determi- 
nations of infarct size and risk area by a dual perfusion tech- 
nique using 4% triphenyltetrazolium chloride mixed with 
phosphate buffer for histochemical staining of dehydrogenase 
enzyme and 0.5% Evan’s blue flow-dependent staining as 
described in detail elsewhere. 7~s Briefly, this method involves 
simultaneous selective left circumflex perfusion with tri- 
phenyltetrazolium and nonselective retrograde aortic perfu- 
sion with Evans blue dye at physiologic pressure (100 mg Hg), 
with the resultant Evan’s blue staining tissue identifying the 
area not at risk of ischemic injury and the remaining tissue 
representing the area at risk with red triphenyltetrazolium 
staining tissue identifying the viable, noninfarcted region, and 
the remaining tissue (unstained) representing the area of in- 
farction. After staining, the heart was sliced from apex to base 
in 5 mm thick transverse sections and the atria and right 
ventricle were excised. Left ventricular weight was recorded 
and left ventricular slices were traced on transparent plastic 
sheets for hand planimeter determination of left ventricular 
area, area at risk, and area of infarction. Infarct size was 
measured as percent of area at risk and percent of total left 
ventricular area. The anatomic perfusion bed of an occluded 
coronary has been shown to correlate well with the area at risk 
of infarction in experimental canine coronary artery occlu- 
sion.lO Subendocardial crystal placement was also confirmed 
at postmortem evaluation. 
Light microscopic evaluation of hematoxylin and eosin 
stained left ventricular slices was performed in a blinded 
manner on 72 hour specimens from all animals in each group 
to assess the morphologic integrity of myocardial cells and the 
inflammatory response. 
Statistical methods: All results are expressed as mean f 
1 standard deviation. Statistical analysis was performed by 
a computerized statistical program of the University of 
Michigan Statistical Research Laboratory (Michigan Inter- 
active Data Analysis System). Two factor analysis of variance 
for repeated measures (profile analysis)i6 was employed for 
the same variable measured more than twice, and paired or 
unpaired t test was performed as appropriate on data mea- 
sured only twice. A probability value (p) less than 0.05 was 
considered significant. 
Results 
Regional myocardial function during coronary 
artery occlusion: In anesthetized, open-chest dogs 90 
minute circumflex coronary artery occlusion resulted 
in a marked alteration of contractile function mani- 
fested by greatly diminished marginal and ischemic 
segment systolic shortening and increased end-diastolic 
and end-systolic segment lengths in all 3 regions, in- 
dicative of ischemia-associated ventricular dilations 
(Fig. 2, Table I). Ibuprofen administration did not de- 
crease these segment length increases or improve sys- 
tolic shortening in any region during coronary artery 
occlusion. In the central ischemic zone, ibuprofen- 
treated animals developed more severe impairment of 
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FIGURE 2. Effect of ibuprofen on regional myocardial 
function after 90 minute left circumflex coronary artery 
occlusion. Marginal and ischemic zone percent systolic 
shortening was reduced in both groups compared with 
preocclusion (paired t test), and ibuprofen animals had 
significantly worse systolic shortening than controls in 
the ischemic zone at the end of the 90 minute occlusion 
(unpaired t test) 
systolic shortening with paradoxic systolic expansion 
(dyskinesia). Heart rate was not altered by ibuprofen 
during coronary occlusion; however, mean carotid artery 
pressure rose significantly with a rise in pressure-rate 
product (the product of mean arterial pressure and 
heart rate divided by 100) (Table I). 
Regional myocardial function 48 and 72 hours 
after coronary artery occlusion-reperfusion: Serial 
changes in regional myocardial function in a control 
animal before, during, and up to 72 hours after coronary 
artery occlusion-reperfusion are shown in Figure 3. 
Similar baseline regional myocardial function was 
present in ibuprofen-treated and control animals in the 
anesthetized, open-chest state before coronary occlusion 
TABLE I Effects of Ibuprofen During Coronary Occlusion 
(Table II, Fig. 4 to 6). In the conscious, unsedated state 
48 and 72 hours after occlusion with myocardial reper- 
fusion, both marginal and ischemic zone systolic 
shortening were impaired despite partial recovery, while 
normal zone systolic function remained relatively un- 
altered. Ibuprofen treatment did not improve systolic 
function or decrease ventricular end-diastolic or end- 
systolic segment lengths in normal, marginal, or ische- 
mic regions at 48 hours or 72 hours before or after ino- 
tropic stimulation. 
A significant reduction in the extent of ischemic 
injury as measured by percent of the area at risk in- 
farcted was noted in ibuprofen-treated animals (44.6 f 
18%) compared with control animals (64.4 f 169’0, p 
Normal Zone 
Heart Rate Mean Arterial Pressure-Rate End-Diastolic End-Systolic % Systolic 
(beats/min) Pressure (mm Hg) Product Length (mm) Length (mm) Shortening 
Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen 
Baseline 167 159 111 120 la7 194 12.6 14.7 9.7 11.5 24.3 21.4 
f25 f17 f14 f20 f46 650 f3.1 f2.4 f3.2 62.3 f9.7 f9.2 
90 minute 171 174 106 137 178 239 14.6 17.1 11.4 13.3 23.0 22.5 
coronary *20 fia f14 f15’ *30 f44’ f4.0 f3.0 f3.9 *3 1 f9.9 410.0 
occlusion 
Marginal Zone lschemic Zone 
End-Diastolic End-Systolic % Systolic End-Diastolic End-Systolic % Systolic 
Length (mm) Length (mm) Shortening Length (mm) Length (mm) Shortening 
Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen Control Ibuprofen 
Baseline 15.0 13.9 12.5 12.1 17.2 14.3 15.6 17.1 13 6 15.3 13.3 11.6 
f2.9 f5 2 43.0 f5.3 f6.3 f9.7 f4.6 f4.6 442 f4.6 *4.2 f5.5 
90 minute la.1 17.2 17.8 16.8 1.7 2.1 la.4 19.7 la.1 20.0 1.3 -1.5 
coronary f2.a f6.0 f3.1 f5.9 f4.4 f5.9 15.4 f5.2 f49 f5.1 f2.7 f2 37 
occlusion 
* p <0.003; t p <0.03 (both unpaired t test). 
Pressure rate product = mean arterial pressure X heart rate divided by 100. Values are mean f 1 standard deviation 
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FKZURE 3. Serial changes in normal, marginal, and central ischemic segment length in a control animal before and at the end of 90 minute circumflex 
occlusion and 48 and 72 hours after reperfusion, and with inotropic stimulation (intravenous prenalterol, 30 pg/kg) at 72 hours. Acute effects of 
circumflex occlusion on regional myocardial function and evolutionary electrocardiographic changes of infarction are demonstrated. BP = blood 
pressure; EKG = lead It electrocardiogram; LCX = left circumflex coronary artery. 
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FIGURE 4. Effect of ibuprofen on normal zone regional myocardial 
function before circumflex occlusion and in conscious, unsedated an- 
imals at 48 and 72 hours and with inotropic stimulation at 72 hours. No 
significant differences were present between groups (analysis of 
variance for repeated measures). IV = intravenous; SD = standard 
deviation. 
- control, n=4 
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FIGURE 6. Effect of ibuprofen on central ischemic zone regional 
function (as in Figure 4). No significant differences between groups were 
present (analysis of variance for repeated measures). 
0 I m CentId, n=7 :! m Ibuprofen (37.5 mg/kp, IV), n ~7 
0 
Pro-Ocdudon 40 bra 72 hrr 72 bra with 
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FIGURE 5. Effect of ibuprofen on marginal area regional function (as 
in Figure 4). No significant differences between groups were present 
(analysis of variance for repeated measures). 
FIGURE 7. Effect of ibuprofen on infarct size. No differences were 
present between ibuprofen and control animals in left (L.) ventricular 
weight or area at risk; ibuprofen significantly reduced infarct size ex- 
pressed as percentage of area at risk (unpaired t test). 
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cO.05, unpaired t test) despite a similar area at risk and 
left ventricular weight (Fig. 7). The percent of total left 
ventricle infarcted was substantially reduced by ibu- 
profen (19.7 f 9.1% versus 26.0 f 5.5% for controls), but 
this did not reach significance (p = 0.12, unpaired t 
test). By visual inspection of stained ventricular slices, 
the predominant area of tissue salvage in ibuprofen- 
treated animals was at the epicardial and lateral mar- 
gins of the infarct. 
Light microscopic analysis of hematoxylin and eosin 
stained left ventricular slices revealed no evident dif- 
ferences in the extent of inflammatory infiltrate or 
hemorrhage or in the appearance of necrotic myocardial 
cells. The appearance of contraction band lesions and 
of fibroblastic proliferation was comparable in both 
groups, 
Visual inspection of the left circumflex coronary 
artery after death demonstrated no detectable 
thrombus in ibuprofen-treated animals and visible 
thrombus in 1 of 8 control animals. 
Discussion 
Rationale for this model: Coronary artery occlusion 
with myocardial reperfusion through a critical stenosis 
as employed in this model may more closely simulate 
the evolution of human myocardial infarction than 
permanent coronary artery occlusion. DeWood et al.17 
demonstrated a progressive decline in the prevalence 
of total coronary occlusion over 24 hours in patients with 
acute myocardial infarction, a finding consistent with 
coronary artery spasm superimposed on fixed ob- 
structive disease’* or with partial resolution of a coro- 
nary artery thrombosis,17 or both. In addition, experi- 
mental animal data indicate that reperfusion may en- 
hance survivallg and improve the likelihood of myo- 
cardial functional recovery.20 Thus, a rationale exists 
for the coronary artery occlusion-reperfusion model of 
myocardial infarction. 
Possible mechanisms of ibuprofen’s myocardial 
protective effect: The present study demonstrates a 
myocardial protective effect of ibuprofen during ex- 
perimental myocardial infarction without improvement 
of normal, marginal, or ischemic regional myocardial 
function during coronary artery occlusion or 48 or 72 
hours after reperfusion or of inotropic reserve at 72 
hours. The reduction in infarct size noted with ibu- 
profen in this study is consistent with previous inves- 
tigations”-’ employing a variety of dosage schedules and 
routes of administration. While the mechanisms of in- 
farct size reduction mediated by ibuprofen have not 
been established, several possibilities have been eval- 
uated. 
First, it is unlikely that ibuprofen exerts a hemo- 
dynamic effect through diminished myocardial oxygen 
consumption or increased myocardial blood flow. 
Jugdutt et al.fi and Romson et al? noted no significant 
effect of ibuprofen on blood pressure or heart rate 
during myocardial ischemia, and the drug has only a 
minimal effect on ventricular contractile force.4 In our 
present study, continuous ibuprofen infusion beginning 
1 hour before ischemia resulted in significant elevations 
of systemic arterial pressure (Table I) without an effect 
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on heart rate after 90 minutes of coronary occlusion. 
This result, not found in previous investigations 
employing different models of ischemia and different 
drug administration schedules, would increase rather 
than decrease myocardial oxygen consumption and thus 
tend to worsen ischemic injury.21 In addition, directly 
measured myocardial oxygen consumption is not altered 
by ibuprofen administration during 60 minutes of 
normothermic global ischemia in the isolated, blood- 
perfused feline heart.i5 
Increased blood flow to ischemic tissue by direct 
coronary artery vasodilation or enhanced collateral 
blood flow is also an unlikely mechanism of ibuprofen’s 
beneficial effect. Tracer microsphere studies in ex- 
perimental myocardial infarction have failed to dem- 
onstrate increased blood flow to ischemic tissue up to 
6 hours6 or 24 hours15 after coronary occlusion in ibu- 
profen-treated experimental animals. 
An antithrombotic effect of ibuprofen is a 2nd pos- 
sible mechanism by which ibuprofen may reduce in- 
farct size.7 In the present study, however, coronary 
artery reperfusion occurred in all animals and only 1 of 
8 control animals developed visible thrombus at 72 hour 
postmortem examination. Also, the antithrombotic 
agent sulfinpyrazone does not appear to reduce infarct 
size.22 Thus, it is improbable that an antithrombotic 
effect of ibuprofen played a role in the present study. 
The potentially related phenomenon of platelet depo- 
sition at the site of ischemic injury also occurs in myo- 
cardial infarction and is diminished by aspirin.23 Ibu- 
profen, however, does not alter indium-111-labeled 
platelet accumulation in the ischemic myocardium.2” 
A 3rd possible mechanism by which ibuprofen may 
exert a myocardial protective effect is its antiinflam- 
matory action, related to inhibition of the arachidonic 
acid pathway.” Cyclooxygenase enzyme inhibition could 
have a beneficial effect in ischemic tissue through a 
reduction in the synthesis of thromboxane, a potent 
vasoconstrictor. However, other nonsteroidal cycloox- 
ygenase inhibitors do not reduce the extent of experi- 
mental ischemic injury.zsJsJe An alternative hy- 
pothesis also related to the arachidonic acid cascade 
which may in part explain ibuprofen’s beneficial effect 
in myocardial ischemia is inhibition of the lipoxygenase 
pathway. This branch of‘the arachidonic acid cascade 
is capable of producing powerful chemotactic sub- 
stances (hydroxyeicosatetraenoic acid [HETE] deriv- 
atives) and leukotrienes, which are additional medi- 
ators of the inflammatory response.27 Ibuprofen has 
been shown to inhibit the synthesis of 12-HETE, cata- 
lyzed by a putative peroxidase enzyme.zs Lipoxygenase 
pathway inhibition may in part account for ibuprofen’s 
ability to inhibit the migration of polymorphonuclear 
leukocytes,2g an effect noted with ibuprofen in experi- 
mental myocardial ischemia.24 
A 4th mechanism of potential significance in ex- 
plaining ibuprofen’s myocardial protective action is 
inflammatory cell lysosomal membrane stabilization, 
an effect suggested by data from noncardiac in vitro 
preparationsa0-:s2 and by indirect evidence in canine 
cardiac ischemia.4 In addition, ibuprofen affects kinin 
and histamine release2 and superoxide radical forma- 
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tiDn,33,34 which may in part account for its anti-in- 
flammatory effect. 
The use of lidocaine in our study could also reduce the 
severity of myocardial ischemic injury.35 Our data, 
however, indicate extensive infarction despite lidocaine 
administration and an additional beneficial effect of 
ibuprofen if lidocaine myocardial preservation oc- 
curred. 
Discordance between infarct size reduction and 
functional recovery: The discrepancy between myo- 
cardial infarct size and functional recovery in this in- 
vestigation may be due to several factors. Improvement 
in regional myocardial function may occur at a time not 
evaluated in this study. A functionally beneficial effect 
of ibuprofen between the onset of reperfusion and 48 
hours cannot be excluded; in the present study a func- 
tional assessment was not performed during that time 
because of marked beat-to-beat segment length changes 
associated with frequent reperfusion arrhythmias. Al- 
ternatively, improvement in myocardial function with 
ibuprofen could occur at a time later than 72 hours. This 
possibility is supported by sonomicrometer crystal data 
in conscious dogs studied up to 4 weeks after 2 hour 
coronary artery occlusion.20 Substantial recovery of 
marginal and ischemic segment systolic shortening oc- 
curred 1 to 4 weeks after coronary artery occlusion- 
reperfusion. Further studies will be necessary to de- 
termine whether ibuprofen treatment alters regional 
myocardial function more than 3 days after myocardial 
infarction. 
Improvement in indexes of myocardial function 
other than subendocardial segment length changes is 
another possible explanation of the discordance be- 
tween infarct size reduction and functional recovery in 
this investigation. Roan et a1.36 noted spontaneous im- 
provement in ischemic zone ventricular wall paradoxic 
systolic thinning between 24 hours and 1 week after 
coronary artery occlusion. Other measures of regional 
function which were not evaluated in this study include 
mid-myocardial and subepicardial segment length 
changes, which may have been altered more than sub- 
endocardial functional measurements in view of pre- 
dominant subepicardial tissue salvage by gross in- 
spection. 
A persistent inability of ibuprofen to significantly 
improve marginal or ischemic region myocardial 
function despite infarct size reduction as determined 
by histochemical staining is also possible. Glucocorti- 
coids have been implicated in “mummification” of 
ischemic myocardium (loss of nuclei with intact myo- 
fibril striations and sarcolemma).37 Such tissue may 
retain the ability to stain dehydrogenase with triphen- 
yltetrazolium despite the loss of functional integrity. 
The absence of such a “mummification” effect on light 
microscopic evaluation in this investigation provides 
evidence against that possibility. 
A recent publication by Kloner et a1.38 demonstrated 
that a 15 minute period of coronary occlusion followed 
by reperfusion, which is not associated with the devel- 
opment of necrosis, nonetheless results in prolonged 
biochemical, functional, and ultrastructural abnor- 
malities. Wall motion, as determined by ultrasonic 
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crystal measurements, was still reduced at 3 days of 
reperfusion, whereas creatine phosphate levels and re- 
gional myocardial blood flow recovered rapidly and had 
returned to normal after 90 minutes of coronary re- 
perfusion. Brief periods (15 minutes) of regional 
ischemia followed by full reperfusion, therefore, can be 
associated with abnormalities in cardiac contractile 
function which persist for a relatively long period. Bush 
et al.sg showed that the biochemical abnormalities as- 
sociated with regional ischemia after reperfusion also 
extend to the normally perfused myocardium. Thus, a 
regional ischemic event may produce an influence on a 
remote region of myocardium which may persist for 









In the present investigation, coronary artery occlusion 
was maintained for 90 minutes and was followed by 
reperfusion in the presence of a critical stenosis. It is 
conceivable that the failure of the salvaged myocardial 
segment to regain contractile function could be related 
to the relatively persistent derangement in segment 
length shortening which is seen even in the absence of 
cellular necrosis. Future attempts to assess the potential 
benefits of pharmacologic interventions in protecting 
ischemic myocardium should consider the functional 
recovery of the “salvaged” myocardium days to weeks 







Implications: Intravenous ibuprofen infusion re- 
duces myocardial infarct size without improving normal, 
marginal, or ischemic region myocardial function during 
coronary artery occlusion or 48 or 72 hours after myo- 
cardial reperfusion, or inotropic reserve at 72 hours. 
Further studies are necessary to assess ibuprofen’s effect 
on regional myocardial function at intervals greater 
than 72 hours after myocardial infarction and to further 
elucidate the mechanisms by which ibuprofen exerts a 
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